Hillstar Bio is a biotechnology company developing immunology therapies that selectively target and deplete pathogenic immune cells to treat autoimmune diseases.

Alesta Therapeutics is a biotechnology company developing oral small molecule therapies for rare diseases.

Actio Biosciences is a biotechnology company that uses its proprietary platform for genetics and precision medicine to develop therapeutics for both rare and common diseases, with a focus on TRPV4 mutations for the treatment of Charcot-Marie-Tooth disease type 2C and other serious bone diseases.